Independent of aPL, SLE patients are at much higher risk of early atherosclerosis and/or thrombosis due to the increased prevalence of classic cardiovascular disease and nontraditional lupus-related risk factors, such as inflammation, renal failure, or corticosteroids12. The gene discussed is FASLG; the disease is deep vein thrombosis.